Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Glaukos stock
Learn how to easily invest in Glaukos stock.
Glaukos Corp is a medical devices business based in the US. Glaukos shares (GKOS) are listed on the NYSE and all prices are listed in US Dollars. Glaukos employs 727 staff and has a trailing 12-month revenue of around $288.3 million.
How to buy shares in Glaukos
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GKOS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Glaukos stock price (NYSE: GKOS)Use our graph to track the performance of GKOS stocks over time.
Glaukos shares at a glance
|Latest market close||$51.11|
|52-week range||$33.33 - $64.49|
|50-day moving average||$52.21|
|200-day moving average||$50.08|
|Wall St. target price||$59.17|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.59|
Buy Glaukos shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Glaukos stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Glaukos price performance over time
|1 week (2022-09-21)||-6.46%|
|1 month (2022-08-26)||2.45%|
|3 months (2022-06-28)||12.06%|
|6 months (2022-03-28)||-9.48%|
|1 year (2021-09-28)||2.28%|
|2 years (2020-09-28)||1.11%|
|3 years (2019-09-27)||61.17|
|5 years (2017-09-28)||54.83%|
Is Glaukos stock undervalued or overvalued?
Valuing Glaukos stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Glaukos's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Glaukos's PEG ratio
Glaukos's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.64. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Glaukos's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$288.3 million|
|Gross profit TTM||$227.4 million|
|Return on assets TTM||-4.75%|
|Return on equity TTM||-9.73%|
|Market capitalisation||$2.4 billion|
TTM: trailing 12 months
Glaukos share dividends
We're not expecting Glaukos to pay a dividend over the next 12 months.
Glaukos share price volatility
Over the last 12 months, Glaukos's shares have ranged in value from as little as $33.33 up to $64.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Glaukos's is 1.4171. This would suggest that Glaukos's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California. .
Glaukos in the news
Glaukos (GKOS) Up on Positive Glaucoma Study Data on iDose TR
Why Glaukos Stock Zoomed Nearly 19% Higher Today
Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate
Frequently asked questionsWhat percentage of Glaukos is owned by insiders or institutions?
Currently 3.958% of Glaukos shares are held by insiders and 95.013% by institutions. How many people work for Glaukos?
Latest data suggests 727 work at Glaukos. When does the fiscal year end for Glaukos?
Glaukos's fiscal year ends in December. Where is Glaukos based?
Glaukos's address is: 229 Avenida Fabricante, San Clemente, CA, United States, 92672 What is Glaukos's ISIN number?
Glaukos's international securities identification number is: US3773221029 What is Glaukos's CUSIP number?
Glaukos's Committee on Uniform Securities Identification Procedures number is: 377322102
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert